Synthetic Biologics, Inc. (SYN) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 24 transactions totaling $18.6M, demonstrating a bullish sentiment with $2.6M in net insider flow. The most recent transaction on May 10, 2021 involved a purchase of 50,000 shares valued at $24.5K.
No significant insider buying has been recorded for SYN in the recent period.
No significant insider selling has been recorded for SYN in the recent period.
Based on recent SEC filings, insider sentiment for SYN is bullish with an Insider Alignment Score of 57/100 and a net flow of $2.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Synthetic Biologics, Inc. (SYN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading SYN stock, having executed 24 transactions in the past 90 days. The most active insider is Randal J. Kirk (Executive), who has made 2 transactions totaling $8.0M.
Get notified when executives and directors at SYN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| May 10, 2021 | A. Shallcross Steven | Executive | Purchase | 50,000 | $0.49 | $24.5K | |
| Aug 23, 2019 | A. Shallcross Steven | Executive | Purchase | 50,000 | $0.42 | $21.0K | |
| Apr 3, 2019 | Intrexon Corp | Executive | Sale | 69,161 | $0.65 | $45.0K | |
| Apr 3, 2019 | Intrexon Corp | Executive | Sale | 26,080 | $0.65 | $17.0K | |
| Apr 2, 2019 | Intrexon Corp | Executive | Sale | 9,909 | $0.66 | $6.5K | |
| Apr 2, 2019 | Intrexon Corp | Executive | Sale | 3,737 | $0.66 | $2.5K | |
| Apr 1, 2019 | Intrexon Corp | Executive | Sale | 30,265 | $0.67 | $20.3K | |
| Apr 1, 2019 | Intrexon Corp | Executive | Sale | 11,413 | $0.67 | $7.6K | |
| Mar 14, 2017 | J. Kraws Jeffrey | Executive | Option Exercise | 228,773 | $0.09 | $20.6K | |
| Nov 18, 2016 | Tarriff Scott | Executive | Award | 300,000 | $N/A | $0 | |
| Sep 2, 2015 | J. Kirk Randal | Executive | Purchase | 937,500 | $3.20 | $3.0M | Large |
| Apr 1, 2015 | Alan Wolf Jeffrey | Executive | Option Exercise | 10,842 | $0.09 | $976 | |
| May 22, 2014 | Evan Ballantyne Charles | Executive | Purchase | 10,000 | $1.35 | $13.5K | |
| Apr 30, 2014 | H. Kanzer Steve | Executive | Sale | 5,003,025 | $1.43 | $7.2M | Large |
| Apr 29, 2014 | H. Kanzer Steve | Executive | Sale | 87,935 | $2.98 | $262.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 12 | $10.6M | 56.8% |
Sale(S) | 9 | $8.0M | 43.1% |
Exercise(M) | 2 | $21.6K | 0.1% |
Award(A) | 1 | $0 | 0.0% |
Insider activity at Synthetic Biologics, Inc. shows mixed signals across all time. While $10.6M in purchases indicates some executive confidence,$8.0M in sales balances the picture, resulting in a modest net flow of $2.6M.9 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Randal J. Kirk, has transacted $8.0M during this period.